Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
203.98
+2.76 (1.37%)
At close: Apr 28, 2026, 4:00 PM EDT
188.98
-15.00 (-7.35%)
After-hours: Apr 28, 2026, 7:59 PM EDT

Jazz Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12,55710,4447,4677,65710,0717,852
Market Cap Growth
102.61%39.87%-2.49%-23.96%28.26%-15.31%
Enterprise Value
15,54112,38110,5907,65710,0717,852
Last Close Price
203.98170.00123.15123.00159.31127.40
PE Ratio
--29.1114.2420.16--
Forward PE
8.447.675.726.298.548.23
PEG Ratio
0.150.550.370.501.140.62
PS Ratio
2.942.451.842.00--
PB Ratio
2.902.421.82---
P/TBV Ratio
2.922.401.99---
P/FCF Ratio
9.688.055.507.17--
P/OCF Ratio
9.267.705.357.01--
EV/Sales Ratio
3.642.902.602.00--
EV/EBITDA Ratio
9.0746.547.696.29--
EV/EBIT Ratio
15.27-28.7814.7813.23--
EV/FCF Ratio
11.989.557.807.17--
Debt / Equity Ratio
1.011.011.49---
Debt / EBITDA Ratio
20.3320.334.47---
Debt / FCF Ratio
4.174.174.53---
Net Debt / Equity Ratio
0.690.690.77---
Net Debt / EBITDA Ratio
11.1511.152.29---
Net Debt / FCF Ratio
2.292.292.32---
Asset Turnover
0.360.360.68---
Inventory Turnover
1.121.121.86---
Quick Ratio
1.461.463.57---
Current Ratio
1.861.864.46---
Return on Equity (ROE)
-8.47%-8.47%27.36%---
Return on Assets (ROA)
-2.06%-2.06%14.25%---
Return on Invested Capital (ROIC)
-3.03%-3.03%21.32%---
Return on Capital Employed (ROCE)
-4.22%-4.22%13.06%---
Earnings Yield
-2.84%-3.44%7.02%4.96%0.00%0.00%
FCF Yield
10.33%12.42%18.19%13.95%0.00%0.00%
Buyback Yield / Dilution
7.61%7.61%8.41%-14.00%--
Total Shareholder Return
7.61%7.61%8.41%-14.00%--
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q